204 related articles for article (PubMed ID: 15229776)
1. Therapy of hepatocellular cancer with iodine-131-Lipiodol.
Risse JH; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
Rom J Gastroenterol; 2004 Jun; 13(2):119-24. PubMed ID: 15229776
[TBL] [Abstract][Full Text] [Related]
2. Randomized controlled trial for hepatocellular carcinoma with portal vein thrombosis: intra-arterial iodine-131-iodized oil versus medical support.
Raoul JL; Guyader D; Bretagne JF; Duvauferrier R; Bourguet P; Bekhechi D; Deugnier YM; Gosselin M
J Nucl Med; 1994 Nov; 35(11):1782-7. PubMed ID: 7525901
[TBL] [Abstract][Full Text] [Related]
3. Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Results in a large German cohort.
Risse JH; Rabe C; Pauleit D; Reichmann K; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H
Nuklearmedizin; 2006; 45(4):185-92. PubMed ID: 16964345
[TBL] [Abstract][Full Text] [Related]
4. 131-iodine Lipiodol therapy in hepatocellular carcinoma.
Raoul JL; Boucher E; Roland V; Garin E
Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):348-55. PubMed ID: 19521315
[TBL] [Abstract][Full Text] [Related]
5. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
[TBL] [Abstract][Full Text] [Related]
6. Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.
Novell JR; Hilson AJ
J Nucl Med; 1994 Aug; 35(8):1318-20. PubMed ID: 8046486
[No Abstract] [Full Text] [Related]
7. Iodine-131-lipiodol therapy in hepatic tumours.
Ahmadzadehfar H; Sabet A; Wilhelm K; Biersack HJ; Risse J
Methods; 2011 Nov; 55(3):246-52. PubMed ID: 21664971
[TBL] [Abstract][Full Text] [Related]
8. Lipiodol drug targeting in the treatment of primary hepatocellular carcinoma.
Kanematsu T; Matsumata T; Furuta T; Shirabe K; Yamagata M; Utsunomiya T; Sugimachi K
Hepatogastroenterology; 1990 Oct; 37(5):442-4. PubMed ID: 2174820
[TBL] [Abstract][Full Text] [Related]
9. Treatment of unresectable hepatocellular carcinoma with transarterial radioembolization: iodine-131-lipiodol.
Lau WY; Lai EC
ANZ J Surg; 2008 May; 78(5):331-2. PubMed ID: 18380721
[No Abstract] [Full Text] [Related]
10. Intra-arterial injection of iodine-131-labeled lipiodol for treatment of hepatocellular carcinoma.
Boucher E; Garin E; Guylligomarc'h A; Olivié D; Boudjema K; Raoul JL
Radiother Oncol; 2007 Jan; 82(1):76-82. PubMed ID: 17141900
[TBL] [Abstract][Full Text] [Related]
11. Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma.
Brans B; Van Laere K; Gemmel F; Defreyne L; Vanlangenhove P; Troisi R; Van Vlierberghe H; Colle I; De Hemptinne B; Dierckx RA
Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):928-32. PubMed ID: 12111134
[TBL] [Abstract][Full Text] [Related]
12. [Repermeability of portal vein after intra-arterial lipiodol chemotherapy in patients with hepatocellular carcinoma. Report of 3 cases].
Derhy S; Bessis L; Atallah R; Ajavon Y; Eisele G; Roche A
Gastroenterol Clin Biol; 1990; 14(11):893-5. PubMed ID: 2177429
[No Abstract] [Full Text] [Related]
13. Adjuvant intra-arterial iodine-131-labeled lipiodol for resectable hepatocellular carcinoma: a prospective randomized trial-update on 5-year and 10-year survival.
Lau WY; Lai EC; Leung TW; Yu SC
Ann Surg; 2008 Jan; 247(1):43-8. PubMed ID: 18156922
[TBL] [Abstract][Full Text] [Related]
14. [Possibility of radiotherapy of hepatic cancer by transcatheter arterial embolization with radioactive Lipiodol].
Kobayashi H; Nakajo M; Shimabukuro K; Shirono K; Sakata H; Oyama T; Sonoda T; Shinohara S
Nihon Igaku Hoshasen Gakkai Zasshi; 1984 Jan; 44(1):96-8. PubMed ID: 6330667
[No Abstract] [Full Text] [Related]
15. [Targeting cancer chemotherapy used Lipiodol as a carrier].
Konno T
Nihon Rinsho; 1989 Jun; 47(6):1384-90. PubMed ID: 2549286
[No Abstract] [Full Text] [Related]
16. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
Takizawa K; Honda M; Obuchi M; Matsuoka S; Shima H; Uchiyama K; Hasebe S; Doai K; Satoh S; Kuniyasu Y
Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
[TBL] [Abstract][Full Text] [Related]
17. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
[TBL] [Abstract][Full Text] [Related]
18. Unusual atrophic change after repeated arterial therapy for hepatocellular carcinoma: report of a case.
Komori T; Sasaki Y; Yamada T; Ohigashi H; Ishikawa O; Inoue E; Ishiguro S; Seki T; Imaoka S
Surg Today; 2004; 34(1):76-9. PubMed ID: 14714235
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up.
Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL
J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267
[TBL] [Abstract][Full Text] [Related]
20. Intraarterial HCC therapy with I-131-Lipiodol.
Risse JH; Grünwald F; Kersjes W; Strunk H; Caselmann WH; Palmedo H; Bender H; Biersack HJ
Cancer Biother Radiopharm; 2000 Feb; 15(1):65-70. PubMed ID: 10740654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
